SO
55
13
LLY
37
4
ALLE
19
3
UNM
63
-2
EXPD
23
2
ADP
66
4
HPE
40
-2
K
65
2
GRMN
52
6
VTR
35
4
WM
54
4
MOS
48
-2
BK
63
2
CTSH
46
-3
PSX
29
4
BAC
56
2
PNR
53
3
IP
54
4
SYK
50
8
FLR
48
-4
SO
55
13
LLY
37
4
ALLE
19
3
UNM
63
-2
EXPD
23
2
ADP
66
4
HPE
40
-2
K
65
2
GRMN
52
6
VTR
35
4
WM
54
4
MOS
48
-2
BK
63
2
CTSH
46
-3
PSX
29
4
BAC
56
2
PNR
53
3
IP
54
4
SYK
50
8
FLR
48
-4
Financhill
Back

USCF Midstream Energy Income Fund Vs. Janux Therapeutics Industry Stock Comparison

Buy
76

UMI
USCF Midstream Energy Income Fund

Last Price:
$51.27
Seasonality Move:
8.57%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Buy
76
USCF Midstream Energy Income Fund (UMI) is a Buy

Is USCF Midstream Energy Income Fund a Buy, Sell or Hold?

  • The current USCF Midstream Energy Income Fund [UMI] share price is $51.38. The Score for UMI is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • UMI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UMI Stock Price Chart

What is USCF Midstream Energy Income Fund's stock price today?

  • The USCF Midstream Energy Income Fund share price today is $51.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UMI is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

UMI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 59.5 Buy
Chaikin Money Flow: 21421 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.17 - 51.45) Buy
Bollinger Bands (100): (44.81 - 50.65) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

UMI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.29 Buy
20-day SMA: 49.88 Buy
50-day SMA: 50.18 Buy
200-day SMA: 44.52 Buy
8-day EMA: 50.48 Buy
20-day EMA: 50.28 Buy
50-day EMA: 49.68 Buy
200-day EMA: 45.17 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

USCF Midstream Energy Income Fund Earnings Growth & UMI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

USCF Midstream Energy Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):